Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07214896Phase 2Enrolling by invitation
Phase 2, open-label trial (4 arms). Primary endpoint: Biometric Audit Score Across Five Performance Dimensions at 30 days. Started Oct 2025; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07214896.